(Q31427584)

2 July 2017

title

Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy (English)

1 reference

2 July 2017

0 references

G Hildebrandt

1

1 reference

2 July 2017

E Holler

2

1 reference

2 July 2017

M Woenkhaus

3

1 reference

2 July 2017

G Quarch

4

1 reference

2 July 2017

A Reichle

5

1 reference

2 July 2017

B Schalke

6

1 reference

2 July 2017

R Andreesen

7

1 reference

2 July 2017

publication date

1 June 2000

1 reference

2 July 2017

1 reference

2 July 2017

volume

11

1 reference

2 July 2017

issue

6

1 reference

2 July 2017

page(s)

743-747

1 reference

From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

DNA duplication associated with Charcot-Marie-Tooth disease type 1A

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Myelin gene dosage and mutation in the hereditary motor and sensory neuropathies: a review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Peripheral myelin protein 22: facts and hypotheses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Charcot-Marie-Tooth Disease Type 1A -- Association with a Spontaneous Point Mutation in the PMP22 Gene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Connexin mutations in X-linked Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Studies on the pathogenesis of vincristine-induced neuropathy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Macrophage-mediated myelin-related mitogenic factor for cultured Schwann cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Polyneuropathy Following Vincristine Therapy in Two Patients With Charcot-Marie-Tooth Syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Vincristine neuropathy in type I and type II charcot‐marie‐tooth disease (hereditary motor sensory neuropathy)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

L2/HNK‐1 carbohydrate and protein‐protein interactions mediate the homophilic binding of the neural adhesion molecule P0

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Neurotoxicity of commonly used antineoplastic agents (first of two parts).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369315240

7 January 2021

Identifiers

DOI

10.1023/A:1008369315240

1 reference

2 July 2017

1 reference